1. In this prospective propensity score (PS)-matched cohort study, lipophilic statins were found to significantly reduce incidence and mortality of hepatocellular carcinoma (HCC).
2. No significant association was found between use of hydrophilic statins and HCC risk.
Evidence Rating Level: 2 (Good)
Study Rundown: The mortality for hepatocellular carcinoma is increasing at...